ZA200903018B - Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte micro-array analysis - Google Patents

Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte micro-array analysis

Info

Publication number
ZA200903018B
ZA200903018B ZA200903018A ZA200903018A ZA200903018B ZA 200903018 B ZA200903018 B ZA 200903018B ZA 200903018 A ZA200903018 A ZA 200903018A ZA 200903018 A ZA200903018 A ZA 200903018A ZA 200903018 B ZA200903018 B ZA 200903018B
Authority
ZA
South Africa
Prior art keywords
immunosuppression
diagnosis
micro
metastatic melanoma
array analysis
Prior art date
Application number
ZA200903018A
Inventor
Anna Karolina Palucka
Jacques F Banchereau
Damien Chaussabel
Original Assignee
Baylor Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor Res Inst filed Critical Baylor Res Inst
Publication of ZA200903018B publication Critical patent/ZA200903018B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Data Mining & Analysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA200903018A 2006-11-03 2009-04-30 Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte micro-array analysis ZA200903018B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85640606P 2006-11-03 2006-11-03

Publications (1)

Publication Number Publication Date
ZA200903018B true ZA200903018B (en) 2010-03-31

Family

ID=39690661

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903018A ZA200903018B (en) 2006-11-03 2009-04-30 Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte micro-array analysis

Country Status (11)

Country Link
US (1) US20100076691A1 (en)
EP (4) EP2080140B1 (en)
JP (1) JP2010508826A (en)
KR (1) KR20090078365A (en)
CN (1) CN101601042A (en)
AU (1) AU2007347118B2 (en)
CA (1) CA2704288A1 (en)
IL (1) IL198360A0 (en)
NZ (3) NZ576428A (en)
WO (1) WO2008100352A2 (en)
ZA (1) ZA200903018B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46843E1 (en) 2005-03-14 2018-05-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for evaluating graft survival in a solid organ transplant recipient
WO2010021696A1 (en) 2008-08-18 2010-02-25 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining a graft tolerant phenotype in a subject
ES2492498T3 (en) 2009-01-15 2014-09-09 The Board Of Trustees Of The Leland Stanford Junior University Biomarker panel for the diagnosis and prediction of graft rejection
EP2507630B1 (en) 2009-12-02 2017-01-25 The Board of Trustees of The Leland Stanford Junior University Biomarkers for determining an allograft tolerant phenotype
US9410205B2 (en) 2010-02-18 2016-08-09 New York University Methods for predicting survival in metastatic melanoma patients
WO2011119980A1 (en) 2010-03-25 2011-09-29 The Board Of Trustees Of The Leland Stanford Junior University Protein and gene biomarkers for rejection of organ transplants
TWI539158B (en) * 2010-06-08 2016-06-21 維里德克斯有限責任公司 A method of predicting the clinical outcome of melanoma patients using circulating melanoma cells in the blood.
CA2818976A1 (en) * 2010-11-26 2012-05-31 Oncolab Diagnostics Gmbh Multimarker panel
CN103403187A (en) * 2011-01-18 2013-11-20 艾沃锐斯特基因有限公司 Prognostic signature for colorectal cancer recurrence
WO2012154935A1 (en) * 2011-05-12 2012-11-15 Eisai R&D Management Co., Ltd. Biomarkers that are predictive of responsiveness or non-responsiveness to treatment with lenvatinib or a pharmaceutically acceptable salt thereof
CN102944539B (en) * 2012-09-24 2015-02-25 杭州师范大学 MGMT activity detection kit and method based on quantum dot resonance energy transfer
US11021752B2 (en) 2013-03-15 2021-06-01 Myriad Genetics, Inc. Genes and gene signatures for diagnosis and treatment of melanoma
JP6496899B2 (en) * 2014-07-01 2019-04-10 公立大学法人福島県立医科大学 Reagent for discriminating invasive meningiomas and method for discriminating the same
EP3164508B1 (en) 2014-07-02 2023-06-07 Myriad myPath, LLC Genes and gene signatures for diagnosis and treatment of melanoma
CN104774252B (en) * 2015-04-03 2018-02-06 西南大学 Transcription factor PtoMYB115 of specific regulatory tannin synthesis and application thereof
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
BR112019024481A2 (en) * 2017-05-25 2020-07-14 Liquid Biopsy Research LLC methods for detecting melanoma
WO2019173283A1 (en) 2018-03-05 2019-09-12 Marquette University Method and apparatus for non-invasive hemoglobin level prediction
AT521641B1 (en) * 2018-09-12 2020-07-15 Fianostics Gmbh Procedure for the diagnosis of liver diseases
CN113748215B (en) * 2018-11-04 2024-07-23 Pfs基因组学公司 Methods and genomic classifiers for prognosis and prediction of benefit from adjuvant radiation therapy in breast cancer
KR102247432B1 (en) 2019-01-21 2021-05-03 주식회사 에스씨엘헬스케어 Biomarker composition for cancer diagnosis and use thereof
IT201900023946A1 (en) * 2019-12-13 2021-06-13 Complexdata S R L Method for determining a long-term survival prognosis of breast cancer patients, based on algorithms that model biological networks
CN111487399B (en) * 2020-03-26 2021-09-17 湖南师范大学 Application of protein molecular marker in research on fish germ cell development
CN113278630B (en) * 2021-05-26 2022-02-15 安徽农业大学 A transcription factor gene MaMYB14 for improving the biosynthesis of mulberry resveratrol and its application
EP4388136A4 (en) * 2021-08-17 2025-07-23 Biomeme Inc Methods for characterizing infections and methods for developing tests therefor
KR102827946B1 (en) * 2022-01-19 2025-06-30 이화여자대학교 산학협력단 A use of PCOLCE2 for predicting leukocyte function promoting of Tonsil-derived mesenchymal stem cell or culture medium thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
CA2124087C (en) 1991-11-22 2002-10-01 James L. Winkler Combinatorial strategies for polymer synthesis
WO1997027317A1 (en) 1996-01-23 1997-07-31 Affymetrix, Inc. Nucleic acid analysis techniques
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
DE69829402T2 (en) 1997-10-31 2006-04-13 Affymetrix, Inc. (a Delaware Corp.), Santa Clara EXPRESSION PROFILES IN ADULTS AND FOLDS ORGANS
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US20050222029A1 (en) * 2001-01-04 2005-10-06 Myriad Genetics, Incorporated Compositions and methods for treating diseases
US6955788B2 (en) 2001-09-07 2005-10-18 Affymetrix, Inc. Apparatus and method for aligning microarray printing head
US8053182B2 (en) * 2004-01-30 2011-11-08 The Trustees Of The University Of Pennsylvania Predictors of transplant rejection determined by peripheral blood gene-expression profiling

Also Published As

Publication number Publication date
WO2008100352A2 (en) 2008-08-21
KR20090078365A (en) 2009-07-17
JP2010508826A (en) 2010-03-25
EP2579174A1 (en) 2013-04-10
CN101601042A (en) 2009-12-09
IL198360A0 (en) 2010-02-17
US20100076691A1 (en) 2010-03-25
EP2080140A2 (en) 2009-07-22
AU2007347118B2 (en) 2012-11-01
EP2506172A1 (en) 2012-10-03
AU2007347118A1 (en) 2008-08-21
EP2080140A4 (en) 2011-08-10
CA2704288A1 (en) 2008-08-21
NZ598954A (en) 2012-10-26
EP2570951A1 (en) 2013-03-20
NZ588574A (en) 2012-07-27
NZ576428A (en) 2012-04-27
EP2080140B1 (en) 2013-04-24
WO2008100352A3 (en) 2008-12-11
HK1131833A1 (en) 2010-02-05

Similar Documents

Publication Publication Date Title
ZA200903018B (en) Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte micro-array analysis
EP1988824A4 (en) Clinical applications of sto2 analysis
ZA201000095B (en) Multiple analysis of blood samples
PL2064993T3 (en) Blood sensor and blood examining instrument including same
GB0616376D0 (en) Raman analysis of tissue
EP2118654A4 (en) Diagnostic test for the detection of a molecule or drug in whole blood
BRPI0913578A2 (en) diagnosis of melanoma and solar lentigo by nucleic acid analysis
IL187859A0 (en) Diagnosis and prognosis of diabetes
EP2217138A4 (en) Sensor unit and procedure for monitoring intracranial physiological properties
EP1906816A4 (en) Mode detection and safety monitoring in blood pressure measurement
EP2114128A4 (en) Monitoring and displaying activities
IL190561A0 (en) Non-invasive glucose monitoring
PL2252212T3 (en) Safety blood collection assembly with indicator
EP1955233A4 (en) Methods and systems for monitoring patients for clinical episodes
EP2152911A4 (en) Diagnosis of melanoma by nucleic acid analysis
EP1937150A4 (en) Probe for ultrasound diagnosis and ultrasound diagnostic system using the same
EP1973462A4 (en) Non-invasive measurement of tear volume systems and methods
EP2223103A4 (en) Fluid sample collecting and analyzing apparatus
GB2450241B (en) Systems and methods for health monitoring of complex systems
EP2299904A4 (en) DEVICES AND METHODS FOR MEDICAL DIAGNOSIS
EP1983892A4 (en) Blood pressure measurement
EP1968648A4 (en) DIAGNOSTIC SYSTEM FOR THE DETECTION AND DIAGNOSIS OF SKIN CANCER
GB0913043D0 (en) Method and device of detecting shape and bone strength diagnostic device using the device
ZA201102086B (en) Measuring and monitoring mental capacity
EP2260107A4 (en) Assays for diagnosing and evaluating treatment options for pompe disease